Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delstrigo for Non-occupational HIV Post-Exposure Prophylaxis
NCT04233372Phase 4Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Aug 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of doravirine in human immunodeficiency virus infection (HIV), sponsored by Hospital Clínic de Barcelona. Started Aug 2020; status: completed.
02
Drugs
doravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04233372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04233372.